Caredx showcases latest advances across alloseq lab products portfolio at the 36th european immunogenetics and histocompatibility conference

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it will showcase the latest developments across its alloseq®* portfolio during the 36th european immunogenetics and histocompatibility conference taking place april 26-29 in nantes, france. “we look forward to par.
CDNA Ratings Summary
CDNA Quant Ranking